Clinical Trial Update: Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Oncoxin-Viusid for cutaneous melanoma has completed, with the study status reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma

Drugs mentioned

• Oncoxin-Viusid

Snippet

Sponsor: Catalysis SL | Conditions: Cutaneous Melanoma, Stage II, Malignant Cutaneous Melanoma | Phase 2 | Status: COMPLETED